Simon P Fletcher Selected Research

isatoribine

9/2005

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon P Fletcher Research Topics

Disease

17	Chronic Hepatitis B 01/2022 - 05/2013
13	Infections 01/2022 - 09/2005
2	Chronic Hepatitis C 01/2012 - 09/2005
1	Reinfection 01/2022
1	Inflammation (Inflammations) 01/2019
1	Hepatitis B 01/2017
1	Thrombocytopenia (Thrombopenia) 06/2015

Drug/Important Bio-Agent (IBA)

6	InterferonsIBA 01/2017 - 01/2012
4	selgantolimodIBA 01/2021 - 01/2020
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2013
4	Toll-Like Receptor 8IBA 01/2021 - 01/2020
4	Toll-Like Receptor 7IBA 01/2018 - 01/2012
3	vesatolimodIBA 01/2018 - 06/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2012
2	NucleotidesIBA 01/2019 - 05/2013
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
2	hepatitis B virus X proteinIBA 01/2019 - 01/2017
2	CytokinesIBA 01/2017 - 09/2012
2	Interferon-alpha (Interferon Alfa)IBA 09/2015 - 03/2014
1	myrcludex-BIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Circular DNAIBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	Viral ProteinsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	EnzymesIBA 06/2015
1	AntigensIBA 03/2014
1	NucleosidesIBA 05/2013
1	Interferon Type IIBA 09/2012
1	ProdrugsIBA 01/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2012
1	isatoribineIBA 09/2005

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2005
1	Aftercare (After-Treatment) 05/2013
1	Ligation 01/2012